| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/06/2003 | US20030027190 Analysis of DNA |
| 02/06/2003 | US20030027189 Luminescent lanthanide metal chelate for use as tool in diagnostic analysis |
| 02/06/2003 | US20030027188 SLC7s as modifiers of the p53 pathway and methods of use |
| 02/06/2003 | US20030027187 Apparatus for use in the analysis of preferential nucleotide sequences |
| 02/06/2003 | US20030027185 Method and kit for diagnosing GH deficiency |
| 02/06/2003 | US20030027184 Detection of preferential aptamer in sample; generate oligonucleotide, incubate with primer and polymerase, amplify and recover nucleotide sequences |
| 02/06/2003 | US20030027183 Method of identifying a nucleic acid sequence in a plant |
| 02/06/2003 | US20030027182 Method of determining the presence of a trait in a plant by transfecting a nucleic acid sequence of a donor plant into a different host plant in an anti-sense orientation |
| 02/06/2003 | US20030027181 Methods for the early diagnosis of ovarian cancer |
| 02/06/2003 | US20030027179 External control reagents for nucleic acid amplification |
| 02/06/2003 | US20030027178 Methods and kits for determining a cancer diagnosis and prognosis |
| 02/06/2003 | US20030027177 Human DNA mismatch repair proteins |
| 02/06/2003 | US20030027176 Classification of bacterial infection in humans; obtain bodily fluid, measure concentration of marker proteins, record marker profile, compare to control, evaluate for bacterial infection |
| 02/06/2003 | US20030027174 Identification of nucleotide sequences specific for mycobacteria and development of differential diagnosis strategies for mycobacterial species |
| 02/06/2003 | US20030027173 Screening for preferential gene activity in plants; obtain plants, propagate, recover plants expressing preferential phenotype, propagate, transform with vector, screen for mutated gene |
| 02/06/2003 | US20030027172 Association of dopamine beta-hydroxylase polymorphisms with bipolar disorder |
| 02/06/2003 | US20030027171 Polypeptide for use in the treatmet of cancer |
| 02/06/2003 | US20030027169 One-well assay for high throughput detection of single nucleotide polymorphisms |
| 02/06/2003 | US20030027167 MRE11: modulation of cellular proliferation |
| 02/06/2003 | US20030027164 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain |
| 02/06/2003 | US20030027163 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/06/2003 | US20030027162 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/06/2003 | US20030027161 Human cDNAs and proteins and uses thereof |
| 02/06/2003 | US20030027160 Terminal labeled probe array and method of making it |
| 02/06/2003 | US20030027159 For multiplex image analysis of chromosomes and chromosomal fragments; diagnose chromosomal abnormalities, infectious agents, etc. |
| 02/06/2003 | US20030027158 Novel nucleic acid sequences encoding human breast tumor-associated protein 47-like polypeptides |
| 02/06/2003 | US20030027157 Determination of oncenntration of nucleotide sequences in sample; obtain sample, incubate with probe, detect signal, quantify nucleotide sequences |
| 02/06/2003 | US20030027156 Generation of preferential proein; obtain nucleotide sequences, incubate with cells, transform cells, express nucleotide sequences, recover proteins |
| 02/06/2003 | US20030027155 Diagnosing preferential cancer in humans; obtain tissue sample, extract nucleotide sequences, detect homozygous deletion of preferential gene, presence of deletion indicates cancer |
| 02/06/2003 | US20030027154 Nucleic acid arrays and method for detecting nucleic acids by using nucleic acid arrays |
| 02/06/2003 | US20030027151 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of bone disorders |
| 02/06/2003 | US20030027150 Method of haplotyping and kit therefor |
| 02/06/2003 | US20030027149 Generation of preferential probe for genome analysis; obtain solid support, incubate with target sequence and probe, detect signal, evaluate hybridization activity of probe |
| 02/06/2003 | US20030027148 Detection of preferential biopolymer in sample; obtain substrate contain biosensor, incubate with sample, expose to probe, detect signal and biopolymer |
| 02/06/2003 | US20030027146 Nucleotide sequences coding polypeptide for use in the treatment of cancer and skin disorders |
| 02/06/2003 | US20030027145 Nucleotide sequences coding polypeptide for use in the treatment of cancer and skin disorders |
| 02/06/2003 | US20030027143 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/06/2003 | US20030027142 Novel genome analyzing method |
| 02/06/2003 | US20030027141 Combinatorial oligonucleotide PCR: a method for rapid, global expression analysis |
| 02/06/2003 | US20030027140 Sequencing preferential nucleic; obtain nucleotide sequences, incubate with primers, amplify, detect signal, sequence |
| 02/06/2003 | US20030027138 DNA markers for assessing seed purity and a method of using DNA sequences for assessing seed purity |
| 02/06/2003 | US20030027136 Rheumatoid arthritis markers |
| 02/06/2003 | US20030027135 Detection of parasite in sample; obtain sample containing parasite, extract nucleotide sequences from parasite, incubate with primer, amplify nucleotide sequences, determine molecular mass, compare to controls in libray of parasites |
| 02/06/2003 | US20030027134 Diagnosing diabetes in humans; obtain sample, extract nucleotide sequences, incubate with probe, record hybridization pattern, compare to control |
| 02/06/2003 | US20030027130 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of viral diseases |
| 02/06/2003 | US20030027127 Diagnostic kit for deection and classificaton of toxic compounds |
| 02/06/2003 | US20030027126 Detection of preferential particles in sample; generate solid support, incubate with sample, detect adjustment in optical properties |
| 02/06/2003 | US20030026857 Method of identifying pharmaceuticals from plant extracts |
| 02/06/2003 | US20030026801 Methods for enhancing antibody-induced cell lysis and treating cancer |
| 02/06/2003 | US20030026800 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
| 02/06/2003 | US20030026793 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions |
| 02/06/2003 | US20030026791 Aids therapy; insertion into cell a virus vector |
| 02/06/2003 | US20030026782 Viricides |
| 02/06/2003 | US20030026781 Compositions and methods for regulating endogenous inhibitor of ATP synthase, including treatment for diabetes |
| 02/06/2003 | US20030026777 Detection and treatment of breast disease |
| 02/06/2003 | US20030026762 Bio-spectral imaging system and methods for diagnosing cell disease state |
| 02/06/2003 | US20030026759 Screening and therapy for lymphatic disorders involving the flt4 receptor tyrosine kinase (vegfr-3) |
| 02/06/2003 | US20030024811 Printing the electrode layer and the first reagent layer on the substrate, one of said print stations printing the electrode layer on the continuous web of substrate and the other printing the first reagent layer on the substrate web |
| 02/06/2003 | CA2857312A1 Nucleic acids, polypeptides, and methods for modulating apoptosis using deoxyhypusine synthase (dhs) |
| 02/06/2003 | CA2454822A1 Nucleic acids, polypeptides, and methods for modulating apoptosis using apoptosis-specific eif-5a |
| 02/06/2003 | CA2454802A1 Novel class ii cytokine receptors and uses thereof |
| 02/06/2003 | CA2454784A1 Identification of specific tumour antigens by means of the selection of cdna libraries with sera and the use of said antigens in diagnostic imaging techniques |
| 02/06/2003 | CA2454570A1 Nanochannel arrays and their preparation and use for high throughput macromolecular analysis |
| 02/06/2003 | CA2454415A1 Homogeneous assay of biopolymer binding by means of multiple measurements under varied conditions |
| 02/06/2003 | CA2454300A1 Parallel or antiparallel, homologous or complementary binding of nucleic acids or analogues thereof to form duplex, triplex or quadruplex complexes |
| 02/06/2003 | CA2454183A1 Methods and compositions for rnai mediated inhibition of gene expression in mammals |
| 02/06/2003 | CA2453437A1 Process for the identification of mutations in a gene |
| 02/06/2003 | CA2450073A1 Compositions and methods for modulating blood-brain barrier transport |
| 02/05/2003 | EP1282061A1 Method for identifying proteins with N-terminal N-myristoylation |
| 02/05/2003 | EP1281967A2 Biochip and method for producing the same |
| 02/05/2003 | EP1281962A1 Method for the screening of compounds that inhibit the interaction between a proline-rich peptide and an SH3 domain comprising peptide |
| 02/05/2003 | EP1281955A1 Biosensor |
| 02/05/2003 | EP1281951A1 Method and device for identification of particles in fluid |
| 02/05/2003 | EP1281775A2 Identification and use of molecules implicated in pain |
| 02/05/2003 | EP1281774A2 Purification of a triple helix formation with an immobilized oligonucleotide |
| 02/05/2003 | EP1281773A1 Method to detect splice variants of the calcineurin gene |
| 02/05/2003 | EP1281772A1 Light-emitting microorganisms and cells for tumour diagnosis/therapy |
| 02/05/2003 | EP1281771A2 Phosphodiesterase 10A cell-based assay and sequences |
| 02/05/2003 | EP1281770A2 Human brain phosphodiesterase and screening method |
| 02/05/2003 | EP1281769A1 Screening-method for inhibitors of folate-synthesis-pathway enzymes |
| 02/05/2003 | EP1281768A1 Drug sensitivity measuring method and device therefor |
| 02/05/2003 | EP1281767A2 Light emitting microorganisms and cells for diagnosis and therapy of tumors |
| 02/05/2003 | EP1281763A2 Early growth response-1 (EGR-1) transcription factor |
| 02/05/2003 | EP1281762A2 Luciferases |
| 02/05/2003 | EP1281761A1 Hepatitis B virus pre-S1 derived synthetic polypeptides and their use thereof. |
| 02/05/2003 | EP1281757A1 Method for the production of nucleic acids consisting of stochastically combined parts of source nucleic acids |
| 02/05/2003 | EP1281755A2 Variants of the human cyp2d6 gene |
| 02/05/2003 | EP1281720A2 Progestogen receptor from Japanese eel |
| 02/05/2003 | EP1281714A1 Magnetic pigment |
| 02/05/2003 | EP1281702A2 Calcium receptor active molecules |
| 02/05/2003 | EP1281154A2 Identifying clusters of transcription factor binding sites |
| 02/05/2003 | EP1281089A1 METHOD FOR CORRELATING BLOOD COAGULATION ACTIVITY WITH MARKERS IN BODY FLUIDS, e.g. URINE |
| 02/05/2003 | EP1281087A2 Early diagnosis of bladder tumor in urine samples |
| 02/05/2003 | EP1281086A2 Mixed cell systems for the detection of viruses |
| 02/05/2003 | EP1281082A1 Method and composition for analyzing a carbohydrate polymer |
| 02/05/2003 | EP1281078A1 Methods for screening and identifying host pathogen defense genes |
| 02/05/2003 | EP1281072A2 Method and device for separating marked biopolymers |
| 02/05/2003 | EP1281063A1 Grating optical waveguide structure for multi-analyte determinations and the use thereof |
| 02/05/2003 | EP1280940A2 Compositions and methods for genetic analyses |
| 02/05/2003 | EP1280939A2 Method for detecting polynucleotides |